These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8912742)

  • 21. Inspiratory maneuver effects on peak expiratory flow. Role of lung elastic recoil and expiratory pressure.
    Tzelepis GE; Zakynthinos S; Vassilakopoulos T; Geroulanos S; Roussos C
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1399-404. PubMed ID: 9372652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchomotor tone and the slope of phase III of the N2-test.
    Olofsson J; Bake B; Skoogh BE
    Bull Eur Physiopathol Respir; 1986; 22(5):489-94. PubMed ID: 3801716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynamic changes in the functional respiratory indices in chronic obstructive lung disease].
    Marinov Kh; Dimitrov D; Shoshkov P; Petrova D; Georgiev O
    Vutr Boles; 1988; 27(4):33-6. PubMed ID: 3213022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
    Sposato B; Mariotta S; Ricci A
    J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a metered-dose aerosol delivery system using partial flow-volume curves.
    Fairshter RD
    Am Rev Respir Dis; 1987 Mar; 135(3):741-3. PubMed ID: 3826899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
    Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
    Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).
    Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P
    Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease.
    Taube C; Lehnigk B; Paasch K; Kirsten DK; Jörres RA; Magnussen H
    Am J Respir Crit Care Med; 2000 Jul; 162(1):216-20. PubMed ID: 10903244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma.
    Frerichs I; Zhao Z; Becher T; Zabel P; Weiler N; Vogt B
    Physiol Meas; 2016 Jun; 37(6):698-712. PubMed ID: 27203725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease].
    Jolly E; Aguirre L; Jorge E; Luna C
    Medicina (B Aires); 1996; 56(5 Pt 1):472-8. PubMed ID: 9239882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of isoprenaline on the mechanical properties of lungs and airways in healthy people and patients with obstructive lung diseases.
    Bobbaers H; Stanescu DC; Demedts SM; Clément J; Pardaens J; van de Woestijne KP
    Bull Eur Physiopathol Respir; 1976; 12(4):515-31. PubMed ID: 1087891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchodilator response in pulmonary disease at two different states of respiratory mechanics.
    Ahmad HR; Rayani HH; Vellani CW; Khan MA; Zaidi SR
    Respiration; 1996; 63(5):288-91. PubMed ID: 8885001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immediate effect of sodium cromoglycate on the airway.
    Hughes D; Mindorff C; Levison H
    Ann Allergy; 1982 Jan; 48(1):6-8. PubMed ID: 6798903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of the flow rate response to low density gas breathing in asthmatics.
    Benatar SR; Clark TJ; Cochrane GM
    Am Rev Respir Dis; 1975 Feb; 111(2):126-34. PubMed ID: 1111400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease.
    Biring MS; Madison S; Mohsenifar Z
    J Asthma; 2001 Sep; 38(6):495-500. PubMed ID: 11642416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Respiratory resistance measured by interrupter technique in asthmatic children. Correlation with spirometry].
    Man SC; Hodor T; Nanulescu MV
    Pneumologia; 2003; 52(3-4):217-20. PubMed ID: 18210738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma.
    Manthous CA; Hall JB; Caputo MA; Walter J; Klocksieben JM; Schmidt GA; Wood LD
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):310-4. PubMed ID: 7842183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of halothane, enflurane and isoflurane on resistance and compliance in patients with asthma or chronic obstructive lung diseases].
    Pasch T; Kamp HD; Petermann H
    Anaesthesist; 1991 Feb; 40(2):65-71. PubMed ID: 2048706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.
    Koumbourlis AC; Motoyama EK; Mutich RL; Mallory GB; Walczak SA; Fertal K
    Pediatr Pulmonol; 1996 Jan; 21(1):28-34. PubMed ID: 8776263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.